Europe Recommends Pfizer Boosters for Ages 18 and Up: Could the U.S. Soon Follow?
16/10 15:01
So far, the U.S. has only authorized boosters for Pfizer's (NYSE: PFE) and BioNTech's (NASDAQ: BNTX) COVID-19 vaccine for individuals ages 65 and up and anyone ages 18 and older who are immunocompromised. However, the European Medicines Agency recently recommended a Pfizer-BioNTe...